Audacity618
Long

$8 target (Short term)

NASDAQ:MACK   MERRIMACK PHARMACEUTICALS INC
65 0 0
Broke the .236 retracement and soon to re-test $6.50. Bullish crosses on 50,100,200. Trial update in Q2 for Phase 3 MM-398. Position: 4,200 shares @4.82
Ideas Scripts Chart
United States
United Kingdom
India
España
France
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out